ES2171886T3 - Sales de morfina y diamorfina de analgesicos anionicos, no narcoticos, tipo acidos carboxilicos sustituidos. - Google Patents

Sales de morfina y diamorfina de analgesicos anionicos, no narcoticos, tipo acidos carboxilicos sustituidos.

Info

Publication number
ES2171886T3
ES2171886T3 ES97903288T ES97903288T ES2171886T3 ES 2171886 T3 ES2171886 T3 ES 2171886T3 ES 97903288 T ES97903288 T ES 97903288T ES 97903288 T ES97903288 T ES 97903288T ES 2171886 T3 ES2171886 T3 ES 2171886T3
Authority
ES
Spain
Prior art keywords
salts
morphine
anionic
diamorfine
narcotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97903288T
Other languages
English (en)
Inventor
Bodo Asmussen
Walter Muller
Walter Riess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2171886T3 publication Critical patent/ES2171886T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION TIENE POR OBJETO SALES DE MORFINA Y DIAMORFINA DE ANALGESICOS ANIONICOS, NO NARCOTICOS, TIPO ACIDOS CARBOXILICOS SUSTITUIDOS, PREFERENTEMENTE LAS SALES DE MORFINA Y DIAMORFINA DEL DICLOFENAC (FORMULA I). LA INVENCION TRATA ASIMISMO DE UN PROCEDIMIENTO PARA SU PREPARACION, DEL EMPLEO DE DICHAS SALES PARA EL TRATAMIENTO DE ENFERMEDADES, ASI COMO DE PREPARACIONES FARMACEUTICAS QUE CONTIENEN LAS SALES EN CUESTION.
ES97903288T 1996-02-28 1997-02-15 Sales de morfina y diamorfina de analgesicos anionicos, no narcoticos, tipo acidos carboxilicos sustituidos. Expired - Lifetime ES2171886T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19607395A DE19607395C2 (de) 1996-02-28 1996-02-28 Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate

Publications (1)

Publication Number Publication Date
ES2171886T3 true ES2171886T3 (es) 2002-09-16

Family

ID=7786595

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97903288T Expired - Lifetime ES2171886T3 (es) 1996-02-28 1997-02-15 Sales de morfina y diamorfina de analgesicos anionicos, no narcoticos, tipo acidos carboxilicos sustituidos.

Country Status (20)

Country Link
US (1) US6156764A (es)
EP (1) EP0883619B1 (es)
JP (1) JP4624497B2 (es)
KR (1) KR100422276B1 (es)
CN (1) CN1064363C (es)
AT (1) ATE212024T1 (es)
AU (1) AU712255B2 (es)
CZ (1) CZ294401B6 (es)
DE (2) DE19607395C2 (es)
DK (1) DK0883619T3 (es)
ES (1) ES2171886T3 (es)
HU (1) HU225268B1 (es)
IL (1) IL125819A (es)
NO (1) NO983864D0 (es)
NZ (1) NZ331485A (es)
PL (1) PL185915B1 (es)
PT (1) PT883619E (es)
SK (1) SK104398A3 (es)
WO (1) WO1997031918A1 (es)
ZA (1) ZA971740B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK4322000A3 (en) * 1997-09-25 2000-10-09 Lohmann Therapie Syst Lts Transdermal or transmucosal composition for administering morphine alkaloids, the application thereof, appropriate compounds and method for their producing
JP4814486B2 (ja) * 2001-06-05 2011-11-16 シヴィダ・インコーポレイテッド 持続放出性鎮痛性化合物
JP2005509631A (ja) * 2001-10-18 2005-04-14 ノバルティス アクチエンゲゼルシャフト At1−レセプターアンタゴニストと心臓血管薬から形成される塩
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) * 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
DK1635875T3 (da) * 2003-06-26 2009-01-12 Psivida Inc In-situ-geldannende lægemiddeladministrationssystem
JP5628467B2 (ja) * 2003-06-26 2014-11-19 シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. 生体分解性徐放性ドラッグデリバリーシステム
US20050196455A1 (en) * 2003-10-27 2005-09-08 Jianbing Chen Suspension delivery system for the sustained and controlled local release of pharmaceuticals
CA2916869A1 (en) * 2004-06-12 2005-12-29 Jane C. Hirsh Abuse-deterrent drug formulations
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
GB8319546D0 (en) * 1983-07-20 1983-08-24 Euro Celtique Sa Pharmaceutical active salts
ZA893422B (en) * 1988-02-24 1991-01-30 Adcock Ingram Lab Ltd Pharmaceutical composition
TW225536B (es) * 1990-08-23 1994-06-21 Ciba Geigy Ag
JPH06506198A (ja) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー 種々な剤形の非ステロイド性抗炎症剤の新規な塩/イオン対
US5256669A (en) * 1992-08-07 1993-10-26 Aminotek Sciences, Inc. Methods and compositions for treating acute or chronic pain and drug addiction
SE9301057L (sv) * 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
GB9319568D0 (en) * 1993-09-22 1993-11-10 Euro Celtique Sa Pharmaceutical compositions and usages
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy

Also Published As

Publication number Publication date
DE19607395C2 (de) 2002-11-21
EP0883619B1 (de) 2002-01-16
HUP9900568A3 (en) 2001-08-28
DK0883619T3 (da) 2002-04-29
US6156764A (en) 2000-12-05
CZ294401B6 (cs) 2004-12-15
KR100422276B1 (ko) 2004-07-30
IL125819A (en) 2002-04-21
CN1212698A (zh) 1999-03-31
PL328712A1 (en) 1999-02-15
EP0883619A1 (de) 1998-12-16
JP2000505463A (ja) 2000-05-09
ATE212024T1 (de) 2002-02-15
HU225268B1 (en) 2006-08-28
ZA971740B (en) 1997-09-04
CN1064363C (zh) 2001-04-11
SK104398A3 (en) 1998-12-02
PL185915B1 (pl) 2003-08-29
KR19990087343A (ko) 1999-12-27
NO983864L (no) 1998-08-21
AU1769597A (en) 1997-09-16
JP4624497B2 (ja) 2011-02-02
PT883619E (pt) 2002-07-31
NO983864D0 (no) 1998-08-21
CZ265798A3 (cs) 1998-11-11
HUP9900568A2 (hu) 1999-06-28
IL125819A0 (en) 1999-04-11
DE19607395A1 (de) 1997-09-04
DE59706015D1 (de) 2002-02-21
WO1997031918A1 (de) 1997-09-04
AU712255B2 (en) 1999-11-04
NZ331485A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
ES2171886T3 (es) Sales de morfina y diamorfina de analgesicos anionicos, no narcoticos, tipo acidos carboxilicos sustituidos.
DK0413528T3 (da) Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse
BRPI0413582A (pt) compostos, composições e métodos para inibir a atividade de proteasome
ES2170104T3 (es) Inhibidores de la produccion de proteinas de beta-amiloide.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
EE9900535A (et) Fumaarhappe derivaatide kasutamine
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
SV2002000022A (es) Inhibidores de recanalizacion de la monoamida para el tratamiento de los desordenes del sistema nervioso central ref. pc10434
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
AR036623A1 (es) Proceso para la preparacion de repaglinida
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
IT1293305B1 (it) Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
DK0845034T3 (da) Peptid med pronociceptive egenskaber
ES2189956T3 (es) Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos.
BR0112131A (pt) Composições farmacêuticas e métodos para uso
ES2211996T3 (es) Agentes de union a receptores de acido hialuronico y su uso para el tratamiento de tumores o de reestenosis.
ES2194129T3 (es) Compuestos farmaceuticos.
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
ES2184150T3 (es) Uso de derivados de los acidos 7-(1-aminometil-2-oxa-7-aza-biciclo(3.3.0)oct-7il)-quinoloncarboxilico y -naftiridoncarboxilico para el tratamiento de infecciones causadas por helicobacter pylori y de las afecciones gastroduodenales asociadas con ellas.
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 883619

Country of ref document: ES